New hope for tough lymphoma: drug combo trial launches
NCT ID NCT07288814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of two drugs, mitoxantrone hydrochloride liposome and enlonstobart, in people with peripheral T-cell lymphoma that has come back or not responded to treatment. The goal is to find the safest and most effective dose and see how well the combo works. About 43 participants will take part in this early-phase trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.